Dachaigh › Melanoma Uveal
Sgrùdaidhean clionaigeach Melanoma Uveal a’ fastadh anns na SA
Tha 22 sgrùdaidhean airson Melanoma Uveal a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Philadelphia, PA7 sgrùdaidhean
- Los Angeles, CA6 sgrùdaidhean
- Nashville, TN6 sgrùdaidhean
- New York City, NY5 sgrùdaidhean
- Boston, MA5 sgrùdaidhean
- Columbus, OH5 sgrùdaidhean
- Houston, TX5 sgrùdaidhean
- Denver, CO5 sgrùdaidhean
- Scottsdale, AZ5 sgrùdaidhean
- Miami, FL4 sgrùdaidhean
- Tampa, FL4 sgrùdaidhean
- Mountain View, CA4 sgrùdaidhean
- Pittsburgh, PA4 sgrùdaidhean
- Aurora, CO4 sgrùdaidhean
- Chicago, IL3 sgrùdaidhean
- Cleveland, OH3 sgrùdaidhean
- Madison, WI3 sgrùdaidhean
- Durham, NC3 sgrùdaidhean
Le stàit
- Arizona5 sgrùdaidhean
- California7 sgrùdaidhean
- Colorado7 sgrùdaidhean
- Florida8 sgrùdaidhean
- Illinois3 sgrùdaidhean
- Massachusetts5 sgrùdaidhean
- Michigan3 sgrùdaidhean
- New York7 sgrùdaidhean
- North Carolina4 sgrùdaidhean
- Ohio8 sgrùdaidhean
- Pennsylvania8 sgrùdaidhean
- Tennessee6 sgrùdaidhean
- Texas5 sgrùdaidhean
- Wisconsin3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05607095Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07804186Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06070012A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07636785Tebentafusp-tebn With LDT in Metastatic UM
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Iuch 2026 · NCT06626516Adjuvant Tebentafusp in High Risk Ocular Melanoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06246149Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT06961357Adjuvant Quisinostat in High-Risk Uveal Melanoma
A’ fastadhÌre 2
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 18 Ògmh 2026 · NCT06932757A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT06940739Neoadjuvant Tebentafusp for Uveal Melanoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Ògmh 2026 · NCT06414590Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Ògmh 2026 · NCT03947385ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
A’ fastadhÌre 2/3
Gach aois · Gach gnè · Air ùrachadh 2 Gibl 2026 · NCT06581406Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Màrt 2026 · NCT07276386Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT04119024Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Màrt 2026 · NCT07364474Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Gach gnè · Air ùrachadh 9 Màrt 2026 · NCT04792463Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Gearr 2026 · NCT06627244Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Dùbh 2025 · NCT06121180Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Samh 2025 · NCT07136181A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2025 · NCT06805825Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.